Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2026-01-07 @ 7:29 PM
Study NCT ID:
NCT07240766
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-21
First Post:
2025-11-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
Sponsor:
Zhejiang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-05-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-15
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-15
First Submit QC Date:
None
Study First Post Date:
2025-11-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-15
Last Update Post Date:
2025-11-21
Last Update Post Date Type:
ESTIMATED